GM23891
LCL from B-Lymphocyte
Description:
ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO; OTC
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Disorders of the Urea Cycle |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Karyotypic analysis before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
OTC |
Chromosomal Location |
Xp21.1 |
Allelic Variant 1 |
; OTC DEFICIENCY |
Identified Mutation |
c.759delA; Exon: 8; codon: 253; nucleotide change: c.759delA; Amino acid or other change; frameshift: restriction site alteration: BbvI, BsePI, Cac8I, FnuDII, Fnu4HI, TseI; disease presentation: neonatal; reference: Yamaguchi et al. [2006]. (http://ureacycle.cnmcresearch.org). |
Remarks |
Clinically affected; autism spectrum disorder; mental retardation/developmental delay; past hyperammonemic events; visual and hearing impairments; self-abusive behavior; self -injurious behavior; neurological evaluation at age 4 revealed: abnormal movements, metabolic encephalopathy and agitation; biochemical evidence: initial NH3, 2600 µmol/L; pathogenic mutation: exon 8, codon 253 deletion A (c.759delA); treatments include: citrulline arginine supplement, sodium phenylbutrate, protein restriction; and liver transplantation. |
Yeeok Kang, Seong-Hyeuk Nam, Kyung Sun Park, Yoonjung Kim, Jong-Won Kim, Eunjung Lee, Jung Min Ko, Kyung-A Lee and Inho ParkEmail, DeviCNV: detection and visualization of exon-level copy number variants in targeted next-generation sequencing data BMC Bioinformatics19: 2018 |
PubMed ID: 30326846 |
Split Ratio |
1:3 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|